In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cyclis Pharmaceuticals Inc.

Division of ArQule Inc.
www.cyclispharma.com

Latest From Cyclis Pharmaceuticals Inc.

Start-Up Previews (9/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cancer Therapeutics, feature Cyclis Pharmaceuticals Inc., Mojave Therapeutics Inc., OncoGeneX Technologies Inc. and Oncologic Inc. Plus these selected Start-Ups across Health Care: CardiacAssist Inc., PharMetrics Inc., Sleep Solutions Inc. and Xoft microTube Inc.

Cyclis Pharmaceuticals Inc.

Normally during the cell cycle, molecular signaling checkpoints prevent cell division in the event of chromosomal shuffling or DNA damage. Cyclis Pharmaceuticals is developing cancer drugs that turn on the deactivated cellular surveillance system, leading to apoptosis and cell death.
BioPharmaceutical

Cancer Therapeutics: Finding a Niche

VCs and CEOs cite the rapid clinical development and recent commercial success of Gleevec and Herceptin as the mere tip of the iceberg of a new generation of gene-based cancer drugs. New treatments are being specifically targeted to genes that up- or down-regulate different characteristics of tumor cells-in particular proliferation, angiogenesis, survival, and apoptosis. We highlight four emerging oncology companies, ranging from firms that have rights to individual compounds against gene targets to those developing broad-based oncology drug delivery platforms.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ArQule Inc.
  • Senior Management
  • Samuel K Ackerman, MD, Pres. & CEO
    Alisa L Billings, CFO
    John K Celebi, Dir., Bus. Dev.
    Chiang J Li, MD, VP, Research
  • Contact Info
  • Cyclis Pharmaceuticals Inc.
    Phone: (781) 278-0900
    333 Providence Hwy.
    Norwood, MA 02062
    USA
UsernamePublicRestriction

Register